FMP
electroCore, Inc.
ECOR
NASDAQ
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
5.84 USD
0.2178 (3.73%)
About
ceo
Mr. Daniel S. Goldberger
sector
Healthcare
industry
Medical - Devices
website
https://www.electrocore.com
exchange
NASDAQ
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
CIK
0001560258
ISIN
US28531P2020
CUSIP
28531P103
Address
200 Forge Way
Phone
973 290 0097
Country
US
Employee
68
IPO Date
Jun 22, 2018
Summary
CIK
0001560258
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
28531P103
ISIN
US28531P2020
Country
US
Price
5.84
Beta
0.93
Volume Avg.
10.35k
Market Cap
35.04M
Shares
-
52-Week
3.829-8.08
DCF
1.13
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.71
P/B
-
Website
https://www.electrocore.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ECOR News
It looks like there's no news available.
